Melatonin review reports sleep improvements in children with autism
A research synthesis reported better sleep quality and longer total sleep time, but its abstract leaves important details about the underlying comparisons unclear.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review reported statistically significant improvements in sleep quality and total sleep time with melatonin in children with autism. However, the abstract does not identify the comparison conditions or treatment durations behind those pooled results. Its analyses of dose and age do not provide enough detail to guide an individual treatment choice.
The abstract omits the study count, combined sample size, comparison conditions, confidence intervals, and treatment durations. These omissions limit assessment of the pooled findings and the dose and age analyses.
What the review examined
Researchers grouped existing studies by medication dose, formulation, treatment course, and children's ages. They examined several sleep measures, so the reported improvements concern specific sleep outcomes rather than a demonstrated change in autism's broader features.
What remains hard to judge
The abstract describes adverse reactions as mild and minimal, but gives no event counts or assessment details. It also reports dose and age patterns without enough information to judge how reliably those patterns support individualized treatment.
The original publication
Factors influencing the effect of melatonin on sleep quality in children with autism spectrum disorder: a systematic review and meta-analysis.
Yang H, Lu F, Zhao X
Sleep Breath · 2025
- PubMed ID
- 40768003
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.